Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Visa

español (ES) (288.28 KB - PDF)

Visa

čeština (CS) (322.23 KB - PDF)

Visa

dansk (DA) (287.53 KB - PDF)

Visa

Deutsch (DE) (289.53 KB - PDF)

Visa

eesti (ET) (276.29 KB - PDF)

Visa

ελληνικά (EL) (335.21 KB - PDF)

Visa

français (FR) (289.25 KB - PDF)

Visa

hrvatski (HR) (307.68 KB - PDF)

Visa

latviešu (LV) (334.28 KB - PDF)

Visa

Malti (MT) (324.47 KB - PDF)

Visa

Nederlands (NL) (287.82 KB - PDF)

Visa

polski (PL) (380.69 KB - PDF)

Visa

português (PT) (288.12 KB - PDF)

Visa

română (RO) (482.45 KB - PDF)

Visa

slovenčina (SK) (324.97 KB - PDF)

Visa

slovenščina (SL) (318.42 KB - PDF)

Visa

suomi (FI) (285.73 KB - PDF)

Visa

svenska (SV) (287.15 KB - PDF)

Visa

Product information

български (BG) (936.84 KB - PDF)

Visa

español (ES) (457.64 KB - PDF)

Visa

čeština (CS) (695.23 KB - PDF)

Visa

dansk (DA) (443.55 KB - PDF)

Visa

Deutsch (DE) (456.17 KB - PDF)

Visa

eesti (ET) (460.88 KB - PDF)

Visa

ελληνικά (EL) (957.24 KB - PDF)

Visa

français (FR) (383.63 KB - PDF)

Visa

hrvatski (HR) (504.46 KB - PDF)

Visa

italiano (IT) (614.01 KB - PDF)

Visa

latviešu (LV) (750.12 KB - PDF)

Visa

lietuvių (LT) (673.01 KB - PDF)

Visa

magyar (HU) (1.07 MB - PDF)

Visa

Malti (MT) (774.79 KB - PDF)

Visa

Nederlands (NL) (445.92 KB - PDF)

Visa

polski (PL) (1.09 MB - PDF)

Visa

português (PT) (456.69 KB - PDF)

Visa

română (RO) (807.04 KB - PDF)

Visa

slovenčina (SK) (711.68 KB - PDF)

Visa

slovenščina (SL) (702.28 KB - PDF)

Visa

suomi (FI) (456.54 KB - PDF)

Visa

svenska (SV) (441.7 KB - PDF)

Visa

Íslenska (IS) (622.5 KB - PDF)

Visa

norsk (NO) (656.3 KB - PDF)

Visa
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Visa

español (ES) (219.22 KB - PDF)

Visa

čeština (CS) (262.67 KB - PDF)

Visa

dansk (DA) (227.42 KB - PDF)

Visa

Deutsch (DE) (218.75 KB - PDF)

Visa

eesti (ET) (221.16 KB - PDF)

Visa

ελληνικά (EL) (268.37 KB - PDF)

Visa

français (FR) (221.14 KB - PDF)

Visa

hrvatski (HR) (227.55 KB - PDF)

Visa

italiano (IT) (191.92 KB - PDF)

Visa

latviešu (LV) (256.74 KB - PDF)

Visa

lietuvių (LT) (210.34 KB - PDF)

Visa

magyar (HU) (210.45 KB - PDF)

Visa

Malti (MT) (250.85 KB - PDF)

Visa

Nederlands (NL) (228.06 KB - PDF)

Visa

polski (PL) (245.92 KB - PDF)

Visa

português (PT) (231.37 KB - PDF)

Visa

română (RO) (434.62 KB - PDF)

Visa

slovenčina (SK) (253.67 KB - PDF)

Visa

slovenščina (SL) (237.31 KB - PDF)

Visa

suomi (FI) (204.11 KB - PDF)

Visa

svenska (SV) (218.51 KB - PDF)

Visa

Íslenska (IS) (185.95 KB - PDF)

Visa

norsk (NO) (222.67 KB - PDF)

Visa

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page